处理和检测 COVID-19 患者的血液样本，以安全地研究细胞表型和细胞因子风暴。
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.
机构信息
Department of Medical and Surgical Sciences for Children and Adults, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy.
National Institute for Cardiovascular Research, Bologna, Italy.
出版信息
Cytometry A. 2020 Jul;97(7):668-673. doi: 10.1002/cyto.a.24009. Epub 2020 Apr 10.
Abstract
The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. © 2020 International Society for Advancement of Cytometry.
摘要
由严重急性呼吸综合征冠状病毒 2 引起的大流行严重涉及到所有在实验室工作的人。可能会收到来自已知感染患者或被认为健康的供体的样本，而且同事可能无症状但能够传播病毒。在临床实验室工作带来了一些安全挑战。几年前，国际细胞分析学会发布了安全分析和分选人类样本的指南，并在最近进行了修订。我们描述了自第一个意大利患者出现以来我们一直遵循的程序，这些程序仅对我们的标准程序进行了微小的修改，因为所有与人相关的样本都存在风险。© 2020 国际细胞分析学会。
相似文献
1
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.处理和检测 COVID-19 患者的血液样本，以安全地研究细胞表型和细胞因子风暴。
Cytometry A. 2020 Jul;97(7):668-673. doi: 10.1002/cyto.a.24009. Epub 2020 Apr 10.
2
Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.基于流式细胞术的未固定严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染细胞和其他传染性病原体的分选程序。
Cytometry A. 2020 Jul;97(7):674-680. doi: 10.1002/cyto.a.24040. Epub 2020 Jun 3.
3
Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.实验室生物安全考虑 SARS-CoV-2 在生物安全级别 2 下的情况。
Health Secur. 2020 May/Jun;18(3):232-236. doi: 10.1089/hs.2020.0021. Epub 2020 Jun 9.
4
Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.体外血液吸附：治疗新型冠状病毒肺炎相关细胞因子风暴综合征的一种选择
Shock. 2020 Nov;54(5):700-701. doi: 10.1097/SHK.0000000000001568.
5
Cytokine Storms: Understanding COVID-19.细胞因子风暴：了解 COVID-19。
Immunity. 2020 Jul 14;53(1):19-25. doi: 10.1016/j.immuni.2020.06.017. Epub 2020 Jun 28.
6
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).对疑似或已知含有严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的标本进行实验室检测时的安全注意事项。
Lab Med. 2020 May 6;51(3):239-242. doi: 10.1093/labmed/lmaa018.
7
COVID-19 Outbreak in Italy: Protecting Worker Health and the Response of the Italian Industrial Hygienists Association.意大利的 COVID-19 疫情爆发：保护工人健康和意大利工业卫生学家协会的应对措施。
Ann Work Expo Health. 2020 Jul 1;64(6):559-564. doi: 10.1093/annweh/wxaa044.
8
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行与输血医学：来自意大利的思考
Blood Transfus. 2020 Mar;18(2):77-78. doi: 10.2450/2020.0071-20.
9
Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.鉴于新型冠状病毒肺炎的各实验室部门指南：印度病理学家和微生物学家协会的建议
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):350-357. doi: 10.4103/IJPM.IJPM_857_20.
10
Cytokine storm induced by SARS-CoV-2.由 SARS-CoV-2 引起的细胞因子风暴。
Clin Chim Acta. 2020 Oct;509:280-287. doi: 10.1016/j.cca.2020.06.017. Epub 2020 Jun 10.
引用本文的文献
1
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients.免疫衰老与疫苗效力：通过对多发性硬化症患者 SARS-CoV-2 特异性细胞的免疫代谢分析揭示
**请注意**：以上译文仅供参考，具体内容可根据实际情况进行调整。
Nat Commun. 2024 Mar 29;15(1):2752. doi: 10.1038/s41467-024-47013-0.
2
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.老年重症 COVID-19 肺炎患者的分子和细胞免疫特征。
Commun Biol. 2022 Jun 16;5(1):590. doi: 10.1038/s42003-022-03537-z.
3
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.血浆细胞因子图谱揭示了 TH2 极化和干扰素在预测 COVID-19 严重程度和生存中的重要性。
Front Immunol. 2022 Mar 21;13:842150. doi: 10.3389/fimmu.2022.842150. eCollection 2022.
4
Mobile technology: A tool for healthcare and a boon in pandemic.移动技术：医疗保健的工具与疫情中的福音。
J Family Med Prim Care. 2022 Jan;11(1):37-43. doi: 10.4103/jfmpc.jfmpc_1114_21. Epub 2022 Jan 31.
5
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).流式细胞术和细胞分选在免疫学研究中的应用指南（第三版）。
Eur J Immunol. 2021 Dec;51(12):2708-3145. doi: 10.1002/eji.202170126. Epub 2021 Dec 7.
6
The Role of Different Inflammatory Indices in the Diagnosis of COVID-19.不同炎症指标在新型冠状病毒肺炎诊断中的作用
Int J Gen Med. 2021 Nov 8;14:7843-7853. doi: 10.2147/IJGM.S337488. eCollection 2021.
7
The role of inflammatory indices in the outcome of COVID-19 cancer patients.炎症指标在 COVID-19 癌症患者结局中的作用。
Med Oncol. 2021 Nov 8;39(1):6. doi: 10.1007/s12032-021-01605-8.
8
Single-cell systems biology, COVID-19, and vaccination.单细胞系统生物学、2019冠状病毒病与疫苗接种
Cytometry A. 2021 May;99(5):427-428. doi: 10.1002/cyto.a.24353. Epub 2021 Apr 21.
9
Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.自噬标志物表达降低和髓系来源抑制细胞扩增与重症 COVID-19 患者 T 细胞反应不良相关。
Front Immunol. 2021 Feb 22;12:614599. doi: 10.3389/fimmu.2021.614599. eCollection 2021.
10
Human Dental Pulp Stem Cells Modulate Cytokine Production by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients.人牙髓干细胞调节2019冠状病毒病患者外周血单个核细胞的细胞因子产生
Front Cell Dev Biol. 2021 Feb 5;8:609204. doi: 10.3389/fcell.2020.609204. eCollection 2020.
本文引用的文献
1
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.严重急性呼吸综合征冠状病毒2（SARS-CoV-2），即导致2019冠状病毒病（COVID-19）的病毒：细胞计数法与全球健康面临的新挑战
Cytometry A. 2020 Apr;97(4):340-343. doi: 10.1002/cyto.a.24002. Epub 2020 Mar 18.
2
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1（SARS-CoV-1）相比，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
3
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.新型冠状病毒的出现：严重急性呼吸系统综合征冠状病毒 2：生物学和治疗选择。
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.00187-20.
4
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
5
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病（COVID-19）疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
6
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
7
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Current gaps in sepsis immunology: new opportunities for translational research.脓毒症免疫学的当前差距：转化研究的新机遇。
Lancet Infect Dis. 2019 Dec;19(12):e422-e436. doi: 10.1016/S1473-3099(19)30567-5. Epub 2019 Oct 17.
10
Comprehensive Phenotyping of T Cells Using Flow Cytometry.使用流式细胞术进行全面的 T 细胞表型分析。
Cytometry A. 2019 Jun;95(6):647-654. doi: 10.1002/cyto.a.23724. Epub 2019 Feb 4.
Zotero 插件